HighTower Advisors
PRPH

HighTower Advisors’s ProPhase Labs PRPH Stock Holding History

HighTower Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,839
Closed -$8.43K – 3904
2025
Q4 		$8.43K Sell
18,839
-4,895
-21% -$13.8K ﹤0.01% 3638
2025
Q3 		$109K Buy
23,734
+789
+3% +$3.05K ﹤0.01% 3523
2025
Q2 		$89.8K Hold
22,945
– – ﹤0.01% 3487
2025
Q1 		$92.8K Sell
22,945
-733
-3% -$3.36K ﹤0.01% 3377
2024
Q4 		$179K Buy
23,678
+5,773
+32% +$81K ﹤0.01% 3231
2024
Q3 		$434K Buy
17,905
+2,768
+18% +$77.9K ﹤0.01% 2502
2024
Q2 		$633K Sell
15,137
-228
-1% -$11.9K ﹤0.01% 2146
2024
Q1 		$993K Sell
15,365
-1,947
-11% -$98.6K ﹤0.01% 1808
2023
Q4 		$782K Hold
17,312
– – ﹤0.01% 1995
2023
Q3 		$756K Buy
+17,312
New +$1.01M ﹤0.01% 1952

Other funds holding PRPH

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

HighTower Advisors's PRPH Position: Q1 2026 in Review

HighTower Advisors sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 18,839 shares — an estimated $8.43K sold.

HighTower Advisors first reported a position in PRPH in Q3 2023 and held it in 10 quarters. The position peaked at $993K in Q1 2024. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.

  • HighTower Advisors reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
  • HighTower Advisors sold 18,839 ProPhase Labs shares in Q1 2026, an estimated $8.43K.
  • HighTower Advisors first reported a position in ProPhase Labs in Q3 2023 and held it in 10 quarters.
  • HighTower Advisors's ProPhase Labs position peaked at $993K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.